|
Initial occupancy in each compartment
|
|
Number of residents susceptible to any MRSA
|
S
|
350
|
observed
|
|
Number of residents colonized with non-USA300
|
I
1
|
79
|
observed
|
|
Number of residents colonized with USA300
|
I
3
|
14
|
observed
|
|
Number of residents co-colonized with non-USA300 and USA300
|
I
b
|
3
|
observed
|
|
Total number of residents
|
N
|
446
|
observed
|
|
Model Parameters
|
|
Probability of admission of MRSA-colonized residents
|
λ
|
0.215
|
estimated
|
|
Discharge rate of susceptibles (per 3 months)
|
γ
S
|
0.101
|
estimated
|
|
Discharge rate of MRSA-colonized (per 3 months)
|
γ
I
|
0.074
|
estimated
|
|
Proportion of residents colonized with non-USA300 at baseline
|
w
1
|
0.823
|
observed
|
|
Proportion of residents colonized with USA300 at baseline
|
w
3
|
0.146
|
observed
|
|
Proportion of residents co-colonized with both strains at baseline
|
w
b
|
0.031
|
observed
|
|
Acquisition rate for non-USA300a
|
b
1n
| | |
|
- generalb
| |
0.029 (0.022, 0.038)
|
estimated
|
|
- w/o ABc
| |
0.020 (0.014, 0.030)
|
estimated
|
|
- with ABd
| |
0.042 (0.030, 0.061)
|
estimated
|
|
Acquisition rate for USA300a
|
b
3n
| | |
|
- generalb
| |
0.006 (0.004, 0.011)
|
estimated
|
|
- w/o ABc
| |
0.004 (0.002, 0.010)
|
estimated
|
|
- with ABd
| |
0.009 (0.005, 0.019)
|
estimated
|
|
Clearance rate for non-USA300a
|
g
n1
| | |
|
- generalb
| |
0.116 (0.088, 0.152)
|
estimated
|
|
- w/o ABc
| |
0.125 (0.086, 0.179)
|
estimated
|
|
- with ABd
| |
0.107 (0.074, 0.163)
|
estimated
|
|
Clearance rate for USA300a
|
g
n3
| | |
|
- generalb
| |
0.137 (0.082, 0.228)
|
estimated
|
|
- w/o ABc
| |
0.155 (0.079, 0.328)
|
estimated
|
|
- with ABd
| |
0.125 (0.064, 0.266)
|
estimated
|
